The Duke Funding Alert newsletter, published every Monday, provides information on all new and updated grants and fellowships added to the database during the prior week. This listserv is restricted to members of the Duke community.
The North American Neuroendocrine Tumor Society (NANETS) was established in 2007 with the mission of furthering neuroendocrine tumor disease diagnosis, treatment and management. Since its inception, NANETS has remained dedicated to this mission through the provision of increased education and research opportunities.
NANETS remains committed to connecting the pioneers in the NET field to the young scientific minds that will make up the next generation of NET experts. It is through research that NANETS engages medical professionals in the early part of their careers to foster the further exploration and advancement of the NET diagnosis and treatment.
This year, NANETS is offering two research grants: the Basic/Translational Science Investigator (BTSI) and the NANETS Clinical Investigator Scholarship (NCIS). These grants support innovative research initiatives and encourage young researchers and scientific clinicians to become NET specialists.
The purpose of the NANETS NCIS and BTSI awards is to encourage clinicians (NCIS) or scientists (BTSI) at the end of their fellowship who have secured a faculty appointment or clinicians (NCIS) or scientists (BTSI) beginning their faculty appointment to pursue research focused on neuroendocrine tumors.
NANETS Basic/Translational Science Investigator (BTSI)
The BTSI is awarded to scientists at the end of their fellowship or in the beginning of their faculty appointment, who are predominantly focused on lab-based, basic/translational research. The BTSI is intended to encourage the scientific inquiry in the field of basic/translational science as it relates to NETs.
NANETS Clinical Investigator Scholarship (NCIS)
The NANETS Clinical Investigator Scholarship encourages clinicians at the end of their fellowship or beginning of their faculty appointment to pursue a clinical career focused on neuroendocrine tumors. The NCIS emphasizes both the professional development of the scientific clinician (whose time is primarily dedicated to patient care) and the potential of the project to directly impact NET patients.
Deadline: Jun. 14, 2019